Understanding the underlying mechanisms of injection site reactions can help patients and healthcare professionals implement effective preventive strategies
Treatment typically begins with 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks until the target dose is reached
Results from the BELIEVE trial showed that after 72 weeks, participants receiving the combination therapy experienced an average weight reduction of 22.1% , significantly outperforming Bimagrumab alone (10.8%) and semaglutide alone (15.7%)
Medication selection also depends on health history, side-effect tolerance, diabetes status, pregnancy plans, medication interactions, insurance, cost, availability, and individual treatment goals
Ozempic (semaglutide) tablet prescribing information
Patients receive individualized care plans, gradual dose titration, and routine monitoring of metabolic markers such as blood sugar and overall health status